WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 51–75 of 127 international scientific journals (Pharmacy)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #51 | ChemMedChem ISSN: 1860-7179 / 1860-7187 | 3.5 | 130 | Q2 | 0.67Q1 | CAS Tier 3 | 2.8% | 304 | John Wiley and Sons Ltd |
| #52 | Current Drug Targets ISSN: 1389-4501 / 1873-5592Top Tier | 3.5 | 129 | Q2 | 0.726Q2 | CAS Tier 4 | 0% | 134 | Bentham Science Publishers B.V. |
| #53 | European Journal of Clinical Pharmacology ISSN: 0031-6970 / 1432-1041 | 3.5 | 128 | Q2 | 0.886Q2 | CAS Tier 3 | 4.2% | 151 | Springer Berlin Heidelberg |
| #54 | AAPS Journal ISSN: 1550-7416 | 3.4 | 141 | Q2 | 0.81Q1 | CAS Tier 3 | 4% | 114 | Springer International Publishing |
| #55 | Expert Opinion on Pharmacotherapy ISSN: 1465-6566 / 1744-7666Top Tier | 3.4 | 104 | Q2 | 0.765Q2 | CAS Tier 3 | 4% | 166 | Taylor and Francis Ltd. |
| #56 | Investigational New Drugs ISSN: 0167-6997 / 1573-0646 | 3.4 | 104 | Q2 | 0.816Q2 | CAS Tier 3 | 3.3% | 156 | Springer US |
| #57 | Journal of Managed Care & Specialty Pharmacy ISSN: 2376-0540 / 2376-1032 | 3.3 | 82 | Q2 | 1.212Q1 | CAS Tier 3 | 8.7% | 162 | Academy of Managed Care Pharmacy (AMCP) |
| #58 | Journal of Pharmacokinetics and Pharmacodynamics ISSN: 1567-567X / 1573-8744 | 3.3 | 77 | Q2 | 0.85Q2 | CAS Tier 3 | 13.6% | 61 | Springer US |
| #59 | Current Pharmaceutical Design ISSN: 1381-6128 / 1873-4286Top Tier | 3.2 | 197 | Q2 | 0.632Q2 | CAS Tier 4 | 3.8% | 397 | Bentham Science Publishers B.V. |
| #60 | British Journal of Clinical Pharmacology ISSN: 0306-5251 / 1365-2125 | 3 | 183 | Q2 | 1Q1 | CAS Tier 3 | 3.2% | 400 | Wiley-Blackwell Publishing Ltd |
| #61 | Current Therapeutic Research-Clinical and Experimental ISSN: 0011-393X / 1879-0313 | 3 | 50 | Q3 | 0.609Q2 | CAS Tier 4 | 0% | 30 | Elsevier Inc. |
| #62 | Expert Opinion on Drug Safety ISSN: 1474-0338 / 1744-764X | 3 | 101 | Q2 | 0.86Q2 | CAS Tier 3 | 3.3% | 160 | Taylor and Francis Ltd. |
| #63 | Molecular Pharmacology ISSN: 0026-895X / 1521-0111 | 3 | 218 | Q2 | 1.15Q1 | CAS Tier 4 | 3.1% | 80 | American Society for Pharmacology and Experimental Therapeutics |
| #64 | Fitoterapia ISSN: 0367-326X / 1873-6971 | 2.9 | 134 | Q3 | 0.511Q2 | CAS Tier 4 | 8% | 217 | Elsevier |
| #65 | Pharmaceutical Development and Technology ISSN: 1083-7450 / 1097-9867 | 2.9 | 79 | Q2 | 0.471Q2 | CAS Tier 4 | 3.8% | 83 | Informa Healthcare |
| #66 | Daru-Journal of Faculty of Pharmacy ISSN: 1560-8115 / 2008-2231 | 2.8 | 68 | Q3 | 0.519Q3 | CAS Tier 4 | 0% | 47 | Springer International Publishing |
| #67 | Journal of Pharmacological Sciences ISSN: 1347-8613 / 1347-8648 | 2.8 | 106 | Q3 | 0.891Q2 | CAS Tier 3 | 3.3% | 140 | Japanese Pharmacological Society |
| #68 | Pharmacogenomics Journal ISSN: 1470-269X / 1473-1150 | 2.8 | 101 | Q2 | 0.76Q2 | CAS Tier 3 | 0% | 56 | Springer Nature |
| #69 | Pharmacology ISSN: 0031-7012 / 1423-0313 | 2.8 | 73 | Q3 | 0.81Q2 | CAS Tier 4 | 3.4% | 78 | S. Karger AG |
| #70 | Revista Espanola De Quimioterapia ISSN: 0214-3429Diamond OA | 2.8 | 37 | Q3 | 0.611Q2 Diamond OA | CAS Tier 4 | 10.5% | 93 | Sociedad Espanola de Quiminoterapia |
| #71 | Fundamental & Clinical Pharmacology ISSN: 0767-3981 / 1472-8206 | 2.7 | 92 | Q3 | 0.671Q2 | CAS Tier 3 | 14.3% | 89 | Wiley-Blackwell Publishing Ltd |
| #72 | Drug Development and Industrial Pharmacy ISSN: 0363-9045 / 1520-5762 | 2.6 | 111 | Q3 | 0.402Q2 | CAS Tier 4 | 4.2% | 118 | Informa Healthcare |
| #73 | Journal of Natural Medicines ISSN: 1340-3443 / 1861-0293 | 2.6 | 65 | Q3 | 0.482Q2 | CAS Tier 4 | 12% | 110 | Springer Singapore |
| #74 | Journal of Pharmaceutical Policy and Practice ISSN: 2052-3211 | 2.6 | 40 | Q2 | 0.74Q1 | CAS Tier 3 | 9.1% | 85 | Springer Nature |
| #75 | Pharmacoepidemiology and Drug Safety ISSN: 1053-8569 / 1099-1557 | 2.6 | 117 | Q3 | 1.041Q1 | CAS Tier 3 | 4.2% | 166 | John Wiley and Sons Ltd |